1. Drug products, including biological products, that contain nanomaterials Publication: Silver Spring, MD : Center for Drug Evaluation and Research, April 2022 Subject(s): Biological Products -- standardsDrug ApprovalDrug DevelopmentNanostructuresUnited StatesUnited States. Department of Health and Human ServicesUnited States. Food and Drug Administration
